Mission Therapeutics has announced the appointment of Dr Bobby Soni to its Board of Directors with immediate effect. Bobby replaces Rob Woodman as the representative for IP Group plc. Bobby is currently Director of Healthcare Investments at Touchstone Innovations, now part of the IP Group plc. He joined Touchstone in 2015 from Novo Seeds, the early stage investment arm of Novo AS where he worked as Investment Director.
